Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2014 08:41 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at Upcoming Investor Conferences

SAN FRANCISCO, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
August 15, 2014 08:10 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders

SAN FRANCISCO, GENEVA and MIAMI, Aug. 15, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel...
August 11, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF

SAN FRANCISCO and GENEVA and NOVATO, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of...
August 04, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

#C4CT Summit Explored Emerging Theories on Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Possible Links to Alzheimer's Disease

SAN FRANCISCO, GENEVA and MINNEAPOLIS, Aug. 4, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a...
August 01, 2014 09:25 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R)

SAN FRANCISCO and GENEVA, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
August 01, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig

SAN FRANCISCO and GENEVA, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 31, 2014 10:48 ET | Source: Amarantus BioScience Holdings, Inc.

The 3rd Alzheimer's-Focused #C4CT Concussion Summit Convenes Today at the United Nations

NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology...
July 30, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Amends LymPro LP-002 Clinical Protocol to Report Interim Data at #C4CT Presentation

SAN FRANCISCO and GENEVA, July 30, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 30, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Registration for the 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interest

NEW YORK and MINNEAPOLIS, July 30, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a...
July 28, 2014 15:16 ET | Source: Amarantus BioScience Holdings, Inc.

Sidney Rice and Ben Utecht Talk to NFL Network's Andrea Kremer and ESPN's Andrew Brandt at Upcoming #C4CT Concussion Awareness Summit at the United Nations

MINNEAPOLIS, SAN FRANCISCO and NEW YORK, July 28, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc....